Coronavirus | Pfizer-BioNTech begin global study of lead vaccine candidate
The study is expected to include about 120 sites globally and could include up to 30,000 participants.
from The Hindu - News https://ift.tt/2Df07oU
from The Hindu - News https://ift.tt/2Df07oU
Comments
Post a Comment